Prevalence of Latent Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A South-East London Cohort Study

被引：0
|
作者：
Paine, Gabriel Wisenfeld [1 ]
Cox, Rosie [1 ]
Evans, Rosa [1 ]
Hudson, Jake [1 ]
Baker, Lucy [1 ]
Simpson, Thomas [1 ]
机构：
[1] Lewisham & Greenwich NHS Trust, Univ Hosp Lewisham, London, England
来源：
LUNG CANCER | 2025年 / 200卷
关键词：
D O I：
10.1016/j.lungcan.2025.108243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
133
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Should immune checkpoint inhibitors be contraindicated in lung cancer patients with latent tuberculosis?
    Haddad, Fady G. H.
    Kattan, Clarisse
    Kattan, Joseph
    IMMUNOTHERAPY, 2020, 12 (11) : 759 - 762
  • [2] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [3] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [4] Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors
    Im, Yunjoo
    Lee, Jeeyun
    Kim, Seok Jin
    Koh, Won-Jung
    Jhun, Byung Woo
    Lee, Se-Hoon
    RESPIRATORY MEDICINE, 2020, 161
  • [5] A study of tuberculosis in an expatriate Nepalese community in South-East London
    Simpson, Thomas
    Stephenson, Eric
    Palchaudhuri, Paramita
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [6] THYROID DYSFUNCTION IN PATIENTS WITH LUNG CANCER RECEIVING IMMUNE CHECKPOINT INHIBITORS: A RETROSPECTIVE, OBSERVATIONAL STUDY
    Kulkarni, Ajinkya
    Baralo, Bohdan
    Kulkarni, Mrunal
    Ellangovan, Rithikaa
    Thirumaran, Rajesh
    CHEST, 2020, 158 (04) : 1465A - 1465A
  • [7] The impact of cancer pain on survival of lung cancer patients receiving immune checkpoint inhibitors
    Wang, S.
    Ye, Z-H.
    Zhang, J.
    Lee, T. T. L.
    Wai, A. K. C.
    Kong, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S890 - S890
  • [8] Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study
    Fujita, Kohei
    Elkington, Paul
    Redelman-Sidi, Gil
    Kanai, Osamu
    Yamamoto, Yuki
    Imakita, Takuma
    Okamura, Misato
    Nakatani, Koichi
    Mio, Tadashi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (11) : 2757 - 2764
  • [9] Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study
    Kohei Fujita
    Paul Elkington
    Gil Redelman-Sidi
    Osamu Kanai
    Yuki Yamamoto
    Takuma Imakita
    Misato Okamura
    Koichi Nakatani
    Tadashi Mio
    Cancer Immunology, Immunotherapy, 2022, 71 : 2757 - 2764
  • [10] Hyperprogression in Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Sehgal, Kartik
    JAMA NETWORK OPEN, 2021, 4 (03)
12345